Healthcare partnerships Amiko specializes in digital respiratory care with Respiro, a platform that integrates data, AI, and connected inhalers. This presents opportunities to partner with pharmacies, hospital systems, and payer networks seeking to improve inhalation technique and adherence in asthma and COPD patients.

Digital health expansion Recent event attendance and demonstrated improvement in inhaler technique across multiple devices indicate strong clinical evidence and market relevance, making Amiko a compelling vendor for digital health initiatives and pharmacy-led services.

Sensor tech collaboration Past partnerships with packaging and device sensor providers point to a readiness to integrate patented sensor tech into add-on or integrated inhaler solutions, offering upsell opportunities with pharma manufacturers and device OEMs.

Financial scale With reported revenue in the high hundreds of millions, Amiko represents a sizable potential customer or partner for enterprise-level solutions, enabling scalable pilots, data-sharing agreements, and joint go-to-market programs.

Competitive landscape Identified as a competitor of Propeller Health in the US suggests a mature market with established players; strategy should emphasize differentiators such as pharmacy-led service evaluations, efficacy data, and integration capabilities with existing healthcare workflows.